Santiago Perez-Lloret And NotVoie percutanée

List of bibliographic references

Number of relevant bibliographic references: 5.

Ident.	Authors (with country if any)	Title
000020	Santiago Perez-Lloret [France] ; María Ver Nica Rey [France] ; James Crispo [Canada] ; Daniel Krewski [Canada] ; Marise Lapeyre-Mestre [France] ; Jean-Louis Montastruc [France] ; Olivier Rascol [France]	Risk of heart failure following treatment with dopamine agonists in Parkinson's disease patients
000224	Santiago Perez-Lloret [France] ; Maria Veronica Rey [France] ; Nelly Fabre [France] ; Fabienne Ory [France] ; Umberto Spampinato [France] ; Jean-Louis Montastruc [France] ; Olivier Rascol [France]	Do Parkinson's disease patients disclose their adverse events spontaneously?
000239	Olivier Rascol [France] ; Joaquim Ferreira [Portugal] ; Laurence Negre-Pages [France] ; Santiago Perez-Lloret [France] ; Lucette Lacomblez [France] ; Monique Galitzky [France] ; Jean-Christophe Lemarie [France] ; Jean-Christophe Corvol [France] ; Jonathan M. Brotchie [Canada] ; Laura Bossi [France]	A proof-of-concept, randomized, placebo-controlled, multiple cross-overs (n-of-1) study of naftazone in Parkinson's disease
000351	Emmanuelle Bondon-Guitton [France] ; Santiago Perez-Lloret [France] ; Haleh Bagheri [France] ; Christine Brefel [France] ; Olivier Rascol [France] ; Jean-Louis Montastruc [France]	Drug-Induced Parkinsonism: A Review of 17 Years' Experience in a Regional Pharmacovigilance Center in France
000502	Santiago Perez-Lloret [France, Argentine] ; Olivier Rascol [France]	Dopamine Receptor Agonists for the Treatment of Early or Advanced Parkinson's Disease

Wicri

This area was generated with Dilib version V0.6.29.
Data generation: Wed May 17 19:46:39 2017. Site generation: Mon Mar 4 15:48:15 2024